[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345983-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345983-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","association-of-primary-tumor-surgery-with-survival-outcomes-in-patients-with-bone-metastases-across-multiple-cancer-types","Association of primary tumor surgery with survival outcomes in patients with bone metastases across multiple cancer types","","Background Synchronous bone metastases (BM) meaningfully affect survival across cancer types, yet the survival value of primary tumor surgery (PTS) in different cancers and patient subgroups remains unclear. This retrospective cohort study evaluates whether PTS confers survival benefits among patients with BM. Methods used SEER data (2010–2019), 53,015 patients, propensity score matching, and Kaplan–Meier plus Cox analyses to assess overall and cancer-specific survival. Results highlight survival improvements in selected cancers and surgery contexts, with important prostate and liver-specific differences. Conclusion PTS can enhance survival for selected BM patients, emphasizing tailored surgical strategies by cancer type and patient characteristics.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/association-of-primary-tumor-surgery-with-survival-outcomes-in-patients-with-bone-metastases-across-multiple-cancer-types/345983/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/association-of-primary-tumor-surgery-with-survival-outcomes-in-patients-with-bone-metastases-across-multiple-cancer-types/345983.png","ImageObject",300,407,{"name":42,"@type":43},"Evangeline","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main goal regarding primary tumor surgery (PTS)?","Question",{"text":63,"@type":64},"To investigate whether PTS improves survival outcomes in patients with bone metastases across multiple cancer types, and to clarify differences by cancer type and surgical extent.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data source and study design were used?",{"text":68,"@type":64},"A retrospective cohort study using the SEER database covering 53,015 patients diagnosed with bone metastases from 2010 to 2019, with propensity score matching to reduce baseline imbalance.",{"name":70,"@type":61,"acceptedAnswer":71},"What survival benefits were observed after PTS, and where did effects differ?",{"text":72,"@type":64},"PTS substantially improved overall and cancer-specific survival for lung, kidney, breast, and bladder cancers; however, prostate cancer showed no overall survival gain with variation by surgery type, and liver cancer improved cancer-specific but not overall survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345983,1790095186,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},13056703019662,"https://ap-avatar.wpscdn.com/avatar/be000253a8e92610077?_k=1778726343310543188","Archives of Orthopaedic and Trauma Surgery (2026) 146:298  \n[https://doi.org/10.1007/s00402-026-06419-9](https://doi.org/10.1007/s00402-026-06419-9)  \nRESEARCH  \nAssociation of primary tumor surgery with survival outcomes inpatients with bone metastases across multiple cancer types  \nPei-Hang Xu1,2 · Bochong Shi1,3 · Tianqi Li4 · Mingkang Tian5,6 · Meng Fang7,1 · Mo Cheng1 · Wending Huang1 · Fei Ren8 · Weiluo Cai1 · Wangjun Yan1  \nReceived: 3 March 2026 / Accepted: 6 July 2026 © The Author(s) 2026  \nAbstract  \nBackground Synchronous bone metastases (BM) have a notable impact on the survival rates of patients across various cancer types. While primary tumor surgery (PTS) has shown potential benefits, its impact across different cancers and patient subgroups needs further clarification. This study aimed to investigate the survival benefits of PTS across various cancer types.  \nMethods This retrospective cohort study analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database, covering 53,015 patients diagnosed with BM from 2010 to 2019. Propensity score matching (PSM) was performed to reduce baseline imbalance. Overall survival (OS) and cancer-specific survival (CSS) were evaluated using Kaplan–Meier analysis and Cox proportional hazards regression.  \nResults PTS substantially improved overall and cancer-specific survival in patients with lung, kidney, breast and bladder cancers. All surgical modalities benefited breast and renal cancer survival. In prostate cancer, PTS produced no overall survival gain; survival varied by surgery type, being better after prostatectomy and worse with local resection. For liver cancer, PTS improved cancer-specific but not overall survival, and the small matched cohort necessitates circumspect interpretation. Conclusion The findings indicate that PTS can significantly enhance survival in selected patients with BM, particularly in lung, kidney, breast, and bladder cancers. Tailoring surgical approaches based on individual cancer type and patient characteristics is crucial to optimizing treatment outcomes. Further studies are required to validate these results and expand the understanding of PTS in cancer management.  \nKeywords Pancancer · Bone metastases · SEER database · Surgery · Prognosis  \nIntroduction  \nBone metastasis (BM) is a significant late-stage manifestation of numerous cancers marked by secondary bone involvement that precipitates severe symptoms and skeletal-related events (SREs), such as pain, spinal cord compression, hypercalcemia, and pathological fractures [1, 2] . Currently, metastatic disease affects more than half of all cancer patients, and the prevalence of BM is notably high among breast (73%), prostate (68%), lung (36%), and kidney (35%) cancers [3, 4] .  \nAdvancements in diagnostic and therapeutic techniques have markedly improved treatment outcomes in many patients. Enhanced imaging technologies now allow for earlier detection of disease progression in those afflicted with BM [5, 6] . The introduction of targeted therapies, including bisphosphonates and denosumab, has been crucial for reducing bone degradation and the frequency of SREs [7– 9] . Furthermore, surgical interventions at metastatic sites are increasingly recognized as vital for managing complications such as pathological fractures or spinal cord compression [10, 11] .  \nPei-Hang Xu, Bochong Shi and Tianqi Li contributed equally to this work.  \nExtended author information available on the last page of the article  \nDespite these advancements, limited studies with small sample sizes have suggested that surgeries targeting the primary tumor may offer additional survival benefits [12–14] . Given that BM generally has a more favorable prognosis than other organ metastases, there is a significant opportunity to tailor treatments specifically for patients with BM to potentially enhance their survival rates [15–17] .  \nHowever, variability in the underlying mechanisms of BM and the recommended i","cbCaipETLFft5pY5","https://ap.wps.com/l/cbCaipETLFft5pY5","pdf",5176833,13,"English","# Abstract\n# Introduction\n# Methods\n## Study subjects\n# Results\n# Conclusion","[{\"question\":\"What is the study’s main goal regarding primary tumor surgery (PTS)?\",\"answer\":\"To investigate whether PTS improves survival outcomes in patients with bone metastases across multiple cancer types, and to clarify differences by cancer type and surgical extent.\"},{\"question\":\"Which data source and study design were used?\",\"answer\":\"A retrospective cohort study using the SEER database covering 53,015 patients diagnosed with bone metastases from 2010 to 2019, with propensity score matching to reduce baseline imbalance.\"},{\"question\":\"What survival benefits were observed after PTS, and where did effects differ?\",\"answer\":\"PTS substantially improved overall and cancer-specific survival for lung, kidney, breast, and bladder cancers; however, prostate cancer showed no overall survival gain with variation by surgery type, and liver cancer improved cancer-specific but not overall survival.\"}]","Association of primary tumor surgery with survival outcomes in patients with bone metastases across multiple cancer types | PDF",1790059606,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db834fd83a76303086c3be72d21ea26d.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e6235f73167723e4b04734b5a1b6731.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68a642819b5a345055799660a9911ead.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f0acd38cd629b433dd0780fbcb7285b.webp",980,1301]